KCTBASE

베체트 장염의 치료
Update on the Treatment of Intestinal Behcet’s Disease

대한류마티스학회지 2014년 21권 4호 p.176 ~ p.181

김경조(Kim Kyung-Jo) - 울산대학교 의과대학 서울아산병원 소화기내과학교실

Abstract

Behcet’s disease is a chronic relapsing disease with un-known etiology, involving the multiorgan system charac-terized clinically by oral and genital aphthae, cutaneous le-sions, and ophthalmologic, neurologic, or gastrointestinal manifestations (or some combination of these). Since in-testinal Behcet’s disease has been treated anecdotally with various therapeutic modalities, clinical evidence regarding the management of intestinal Behcet’s disease is still lacking. 5-aminosalycylic acid, corticosteroids, immunos-uppressants, and surgical therapy have been considered as traditional therapies for intestinal Behcet’s disease. The treatment with thalidomide and anti-TNF agents, such as infliximab or adalimumab, is increasing. Future clinical trials are still needed.

키워드

Intestine, Behcet’s disease

KMID : 0388220140210040176

원문 및 링크아웃 정보

등재저널 정보

주제코드

주제명(Target field)

연구대상(Population)

연구참여(Sample size)

대상성별(Gender)

질병특성(Condition Category)

연구환경(Setting)

연구설계(Study Design)

연구기간(Period)

중재방법(Intervention Type)

중재명칭(Intervention Name)

키워드(Keyword)

유효성결과(Recomendation)

연구비지원(Fund Source)

근거수준평가(Evidence Hierarchy)

출판년도(Year)

참여저자수(Authors)

대표저자

DOI

KCD코드

ICD 03

건강보험코드

베체트 장염의 치료 Update on the Treatment of Intestinal Behcet’s Disease

Abstract

키워드

베체트 장염의 치료
Update on the Treatment of Intestinal Behcet’s Disease